KraneShares MSCI All China Health Care Index ETF Price & Performance (KURE)

China's healthcare sector is gaining attention as its population over 60 is projected to more than double by 2050. This demographic shift is expected to drive unprecedented demand for healthcare services. ETFs like KURE offer exposure to key players in biotechnology and medical devices, presenting a growth opportunity for investors.123

China's medical technology firms are leveraging AI to revolutionize healthcare. Companies like Mindray are introducing AI-powered care systems, while Akeso's cancer treatment breakthroughs highlight the sector's innovation. These advancements, coupled with favorable trade balances, position China's healthcare sector for global growth.342

Supportive regulatory changes in China are encouraging private investments in innovative medicine and expanding insurance coverage for drug development. These measures, alongside the sector's insulation from geopolitical tensions, make healthcare an attractive area for investment through vehicles like the KURE ETF.135